COVID-19 surges across the globe as countries report new records.
Brazil this week became just the third country, after the U.S. and Peru, to report a 24-hour tally of COVID-19 deaths that exceeded 4,000.
Brazil this week became just the third country, after the U.S. and Peru, to report a 24-hour tally of COVID-19 deaths that exceeded 4,000.
The detection of additional variants adds to concerns that a brutal COVID-19 wave battering Brazil may keep breaking grim records for weeks to come.
The rapid spread of the P.1 variant in some parts of Canada has added new urgency to the race between variants and vaccines.
On this episode of the Global News podcast What Happened To…?, journalist Erica Vella revisits the Zika virus epidemic.
Public Health England said it is "taking swift and decisive action to deploy surge asymptomatic testing as well as increasing sequencing of positive samples from the area."
The Trudeau government has scaled back plans for a watchdog to investigate allegations of overseas human rights abuses by Canadian companies, activists say.
The restrictions are set to end under a new proclamation from Trump the same day that new COVID-19 test requirements take effect for all international visitors.
"It's not a 100 meter sprint," said Marco Krieger, vice-president of health production and innovation at the Fiocruz institute, in an interview.
Health Minister Eduardo Pazuello had announced the purchase Tuesday in a meeting with Sao Paulo Gov. Joo Doria, a foe of Bolsonaro's whose state is participating in the vaccine's development through its Butantan Institute.
Health Minister Eduardo Pazuello had announced the purchase Tuesday in a meeting with Sao Paulo Gov. Joo Doria, a foe of Bolsonaro's whose state is participating in the vaccine's development through its Butantan Institute.
The Brazilian Health Ministry reported that the death toll now stands at 150,198.
Manaus Mayor Arthur Virgilio blamed right-wing President Jair Bolsonaro, who has minimized the gravity of the pandemic, for encouraging a return to normal life and work instead of waiting for a vaccine to be developed.